Forecast

There is no analyst data available for this company.

News Go to news feed

Arjo increases organic sales growth, margins hit by US tariffs and currency effects

Arjo reports Q1 2026 organic sales growth of 3.8%, with adjusted EBITDA of 456 million SEK and an EBITDA margin of 16.9%. Gross margin fell by 110 basis points to 42.6%, weighed notably by US tariffs (‑0.4 percentage points), an unfavorable product and country mix, and currency effects that reduced gross profit by 123 million SEK. Regional divergence: North America +2.2%, Western Europe ‑2.9%, Rest of World +30.0% (large order in South Africa). Management announces a strategic realignment with new financial targets for the second half of 2026 and highlights improved cash conversion (52.7%) and declining net debt as signs of financial strengthening. » More on de.investing.com
Arjo: share falls after Q4 and full-year figures despite organic growth due to margin pressure

Arjo reported organic growth of 3.4% in Q4/2025 and annual sales of SEK 11 billion, but showed significant profitability pressure with a declining gross margin (44.7% to 42.1%) and an adjusted EBIT margin of 8.9%. Causes cited include currency effects, US tariffs, an unfavorable product and regional mix, and pricing pressure in the US; net debt and cash flow improved slightly. The share fell about 11% after the results; management confirmed the outlook of 3–5% organic revenue growth for 2026 and plans a strategy review with new financial targets for H2 2026. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2026, ARJO AB B has already paid 0,0874€ in dividends. The last payout was in April.

Financials

In the last quarter, ARJO AB B had revenue of 248,96 Mio€ and net profit of 11,28 Mio€

(EUR)	Jun 2026	YoY
Revenue	+248,96 Mio	3,59%
Gross profit	+96,55 Mio	7,41%
Net profit	+11,28 Mio	36,61%
EBITDA	+43,13 Mio	1,18%

Fundamentals

Metric	Value
Market capitalization	+689,05 Mio€
Number of shares	272,37 Mio
52-week high/low	+3,19€ - +2,13€
Dividend yield	+3,45%
Dividends TTM	+0,0874€
Beta	0,69
P/E ratio	+19,76
PEG ratio	−1,95
P/B ratio	+0,99
P/S ratio	+0,70

Company profile

Arjo AB (publ) entwickelt und vertreibt medizinische Geräte und Lösungen für Patienten mit eingeschränkter Mobilität und altersbedingten Gesundheitsproblemen in Nordamerika, Westeuropa und international. Das Unternehmen bietet Produkte und Lösungen für Patientenhandhabung, Hygiene, Desinfektion, medizinische Betten, Behandlung und Vorbeugung von Druckverletzungen und Beingeschwüren, Vorbeugung von tiefen Venenthrombosen, Behandlung von Ödemen und für Geburtshilfe und Herzdiagnostik. Darüber hinaus bietet das Unternehmen Lösungen für die Bewertung von Demenz- und Bariatriezimmern sowie klinische Beratung, Wartung und Miet- und Finanzierungslösungen für Geräte an. Das Unternehmen beliefert private und öffentliche Einrichtungen, die Akut- und Langzeitpflege anbieten. Das Unternehmen wurde 1957 gegründet und hat seinen Hauptsitz in Malmö, Schweden.

Name	ARJO AB B
CEO	Andreas Elgaard
Headquarters	Malmö, sn Sweden
Website	arjo.com
Sector	Health Care
Industry	Health Care Equipment & Supplies
IPO	01/15/2014
Employees	7.000